CDC Logo Skip Top Nav
CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 

This is an archived document. The links and content are no longer being updated.

Table 8. Resistance to Isoniazid with or without Rifampin Resistance in Reported TB Cases with No Previous TB by Origin: United States, 1993-2002

Return to 2002 Surveillance Report

Year
Resistant to Isoniazid1
Resistant to Isoniazid and Rifampin1
Total Cases2
U. S.-born
Foreign-born3
Total Cases2
U. S.-born
Foreign-born3
No.
%
No.
%
No.
%
No.
%
No.
%
No.
%
1993
1,401
8.4
805
6.8
579
12.4
410
2.5
302
2.6
105
2.3
1994
1,355
8.3
709
6.4
632
12.1
352
2.2
238
2.2
109
2.1
1995
1,172
7.3
554
5.4
617
11.0
252
1.6
168
1.6
84
1.5
1996
1,136
7.4
494
5.2
639
11.3
206
1.3
104
1.1
101
1.8
1997
1,080
7.5
437
5.0
639
11.2
155
1.1
76
0.9
79
1.4
1998
1,012
7.5
366
4.7
644
11.3
131
1.0
55
0.7
75
1.3
1999
904
7.1
284
4.0
618
11.0
128
1.0
39
0.6
89
1.6
2000
893
7.5
270
4.3
620
11.0
121
1.0
38
0.6
83
1.5
2001
806
7.1
245
4.4
560
9.6
116
1.0
34
0.6
82
1.4
2002
778
7.5
197
4.0
574
10.6
121
1.2
37
0.8
83
1.5
1Isolates may be resistant to other drugs.
2Includes persons of unknown country of birth.
3Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacific islands.
Note:  Data for all years updated through March 28, 2003.
More than 85% of all cases in each group had drug susceptibility test results reported for an initial isolate.
See Surveillance Slides #18, #19, #20, and #21.

 

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Back to Top of Page

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: tbinfo@cdc.gov

Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov